Risperidone plasma level, and its correlation with CYP2D6 gene polymorphism, clinical response and side effects in chronic schizophrenia patients

被引：0
|
作者：
Xiaoyi Wang
Jing Huang
Jianjun Lu
Xuemei Li
Hui Tang
Ping Shao
机构：
[1] The Second Xiangya Hospital of Central South University,Department of Psychiatry, National Clinical Research Center for Mental Disorders, and National Center for Mental Disorders
[2] The Third People’s Hospital of Jiangyin City,undefined
[3] People’s Hospital of Dali Prefecture,undefined
来源：
BMC Psychiatry | / 24卷
关键词：
Risperidone; Chronic schizophrenia; Plasma concentration; polymorphism; Effect; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Genetic polymorphism of CYP2D6 in patients with cardiovascular disease - a cohort study
    Teh, LK
    Zilfalil, BA
    Marina, I
    Rosemi, BS
    Ismail, R
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2004, 29 (06) : 559 - 564
  • [32] CYP2D6 polymorphism in relation to tramadol metabolism: A study of Faroese patients
    Halling, Jonrit
    Weihe, Pal
    Brosen, Kim
    THERAPEUTIC DRUG MONITORING, 2008, 30 (03) : 271 - 275
  • [33] Correlation between CYP2D6*10 Gene Mutation, and Structure and Function of its Encoding Protein
    Li, Ju-yi
    Wang, Xiu-fang
    Zhang, Zhao-qing
    Chen, Yong-gang
    Zou, Ji-li
    Wang, Xiong
    Wu, Jin-hu
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2014, 13 (03) : 347 - 351
  • [34] The Influence of the CYP3A4*22 Polymorphism and CYP2D6 Polymorphisms on Serum Concentrations of Aripiprazole, Haloperidol, Pimozide, and Risperidone in Psychiatric Patients
    van der Weide, Karen
    van der Weide, Jan
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2015, 35 (03) : 228 - 236
  • [35] Association of CYP2D6*4 gene polymorphism with early papillary thyroid carcinoma
    Aday, Aynur Daglar
    Ozturk, Tulin
    Teker, Basal Akadam
    Aksoy, Figen
    Aydogan, Hulya Yilmaz
    Ozturk, Oguz
    Isbir, Turgay
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2021, 46 (04): : 455 - 460
  • [36] Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer's disease patients
    Varsaldi, Federica
    Miglio, Gianluca
    Scordo, Maria Gabriella
    Dahl, Marja-Liisa
    Villa, Laura Maria
    Biolcati, Aldo
    Lombardi, Grazia
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (09) : 721 - 726
  • [37] Impact of the CYP2D6 polymorphism on steady-state plasma concentrations and clinical outcome of donepezil in Alzheimer’s disease patients
    Federica Varsaldi
    Gianluca Miglio
    Maria Gabriella Scordo
    Marja-Liisa Dahl
    Laura Maria Villa
    Aldo Biolcati
    Grazia Lombardi
    European Journal of Clinical Pharmacology, 2006, 62 : 721 - 726
  • [38] CYP2D6 polymorphism studies: How forensic genetics helps clinical medicine
    Riccardi, Laura Natalia
    Bini, Carla
    Ceccardi, Stefania
    Trane, Rachele
    Luiselli, Donata
    Pelotti, Susi
    FORENSIC SCIENCE INTERNATIONAL GENETICS SUPPLEMENT SERIES, 2009, 2 (01) : 485 - 486
  • [39] CYP2D6 and ABCB1 genetic variability:: Influence on paroxetine plasma level and therapeutic response
    Gex-Fabry, Marianne
    Eap, Chin B.
    Oneda, Beatrice
    Gervasoni, Nicola
    Aubry, Jean-Michel
    Bondolfi, Guido
    Bertschy, Gilles
    THERAPEUTIC DRUG MONITORING, 2008, 30 (04) : 474 - 482
  • [40] CYP2D6*4 polymorphism is associated with statin-induced muscle effects
    Frudakis, Tony N.
    Thomas, Matthew J.
    Ginjupalli, Siva N.
    Handelin, Barbara
    Gabriel, Richard
    Gomez, Hector J.
    PHARMACOGENETICS AND GENOMICS, 2007, 17 (09) : 695 - 707
12345